News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Will Johnson & Johnson (JNJ) Bid for the Rest of Elan Corporation PLC (ELN)?



7/9/2012 7:06:33 AM

Elan, which may be on the cusp of the biggest drug discovery ever unveiled by an Irish company, may be taken over by its partner Johnson & Johnson, if crucial trials work. Johnson & Johnson already owns 18.4 per cent of €6.9bn-valued Elan, following a complex deal which sees the US drug giant fund much of the research costs of its potential Alzheimer's wonder drug. Coming weeks will see key milestones for Elan and its partners as they await the results of trials before seeking to have the drug cleared by regulators.

Read at Independent


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES